{"schema_version":"secwatch.filing_event.v1","accession":"0001393052-24-000019","form_type":"8-K","ticker":"VEEV","cik":"0001393052","company_name":"VEEVA SYSTEMS INC","filed_at":"2024-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.207729+00:00","generated_at":"2026-06-01T07:21:44.636171+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Veeva Q1 FY2025 revs $650.3M (+24% YoY); non-GAAP EPS $1.50 vs $0.91, beat guidance","bullets":["Total revenue $650.3M (+24% YoY); subscription revenue $534.0M (+29% YoY).","GAAP net income $161.7M ($0.98 diluted EPS); non-GAAP net income $247.0M ($1.50 diluted EPS).","GAAP operating income $155.2M (+152% YoY); non-GAAP op income $260.9M (+66% YoY).","Three top-20 biopharmas selected multiple Development Cloud apps; Vault Basics launched for emerging biotechs.","Interim CFO Tim Cabral noted results exceeded guidance on all metrics."],"urls":{"canonical":"https://secwatch.observer/filing/0001393052-24-000019","json":"https://secwatch.observer/filing/0001393052-24-000019.json","markdown":"https://secwatch.observer/filing/0001393052-24-000019.md","text":"https://secwatch.observer/filing/0001393052-24-000019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1393052/000139305224000019/0001393052-24-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1393052/000139305224000019/veev-20240530.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:21:44.636171+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}